Citation Impact
Citing Papers
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody
2016
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
2013 Standout
Antiangiogenesis Enhances Intratumoral Drug Retention
2011
Leukotriene E4–induced pulmonary inflammation is mediated by the P2Y12 receptor
2009
Cancer statistics, 2022
2022 Standout
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
2016 StandoutNobel
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2017
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Tumor angiogenesis: causes, consequences, challenges and opportunities
2019
Cancer Statistics, 2021
2021 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
2014
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer
2014
Nucleotide signalling during inflammation
2014 StandoutNature
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (F e NO ) for Clinical Applications
2011 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
2014 Standout
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Nitric oxide and pulmonary arterial pressures in pulmonary hypertension
2004
IgE and mast cells in allergic disease
2012 Standout
Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial
2016
Hepatocellular carcinoma
2021 Standout
Lung cancer: New biological insights and recent therapeutic advances
2011
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial
2015
ESMO-Magnitude of Clinical Benefit Scale version 1.1
2017
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Asthma
2017 Standout
Targeting Tumor Mitochondrial Metabolism Overcomes Resistance to Antiangiogenics
2016
Antiangiogenic therapy—evolving view based on clinical trial results
2012
Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine–cisplatin plus necitumumab versus gemcitabine–cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer
2016
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Acute kidney injury
2019 Standout
Extracellular matrix structure
2015 Standout
Treatment Paradigms for Patients with Metastatic Non-Small Cell Lung Cancer, Squamous Lung Cancer: First, Second, and Third-Line
2014
The development of allergic inflammation
2008 StandoutNature
Targeting apoptosis in cancer therapy
2020 Standout
Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer
2017
Mediators of Chronic Obstructive Pulmonary Disease
2004
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
2016 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis
2011
Modeling and predicting clinical efficacy for drugs targeting the tumor milieu
2012
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Association between air pollution exposure and exhaled nitric oxide in an elderly population
2004
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Evolution of the mammary gland from the innate immune system?
2006 StandoutNobel
Outdoor air pollution and asthma
2014 Standout
Acute effects of cigarette smoke on inflammation and oxidative stress: a review
2004
Cancer-related inflammation and treatment effectiveness
2014 Standout
Apo2L/TRAIL and the Death Receptor 5 Agonist Antibody AMG 655 Cooperate to Promote Receptor Clustering and Antitumor Activity
2014
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Acute Effects of Air Pollution on Pulmonary Function, Airway Inflammation, and Oxidative Stress in Asthmatic Children
2009
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
2014 StandoutNobel
Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation
2007
Protein S-nitrosylation: purview and parameters
2005 Standout
Oxidative Stress in Airways
2002
Clinical Use of Noninvasive Measurements of Airway Inflammation in Steroid Reduction in Children
2005
Superoxide Dismutases in the Lung and Human Lung Diseases
2003
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer
2013
Activation of TLR-9 Induces IL-8 Secretion through Peroxynitrite Signaling in Human Neutrophils
2006
Health Effects of Fine Particulate Air Pollution: Lines that Connect
2006 Standout
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
2012
Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation
2011
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
2017 Standout
Targeted therapies for treatment of non‐small cell lung cancer—Recent advances and future perspectives
2015
Meta-Analysis of Randomized Controlled Trials for the Incidence and Risk of Treatment-Related Mortality in Patients With Cancer Treated With Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors
2012
Antiangiogenesis beyond VEGF inhibition: A journey from antiangiogenic single-target to broad-spectrum agents
2013
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Nitric oxide represses inhibitory κB kinase through S-nitrosylation
2004
Nephrotoxicity of anticancer treatment
2016
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Acute Effects of Air Pollution on Pulmonary Function, Airway Inflammation, and Oxidative Stress in Asthmatic Children
2008
The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies
2009
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2015
Targeted therapy for non-small cell lung cancer: current standards and the promise of the future.
2015
Programmed co-delivery of platinum nanodrugs and gemcitabine by a clustered nanocarrier for precision chemotherapy for NSCLC tumors
2019
Works of Beatrix Bálint being referenced
The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD
2015
A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
2013
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
2015
Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis
2001
Nitric Oxide Metabolites Are Not Reduced in Exhaled Breath Condensate of Patients With Primary Ciliary Dyskinesia*
2003
Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke
2001
Increased Leukotrienes in Exhaled Breath Condensate in Childhood Asthma
2002
Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer
2010
Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke
2001
C6-01: Correlations of biomarker expression and clinical outcome in a large phase III trial of pemetrexed plus cisplatin or gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
2007